Cardiprin (Aspirin) in Pregnancy: Risks, Indications & Dosing Guidance

Cardiprin is a brand of low-dose aspirin (typically 100 mg enteric-coated). Use in pregnancy is indication-specific—not routine.

Contraindicated / Avoid

  • First trimester (organogenesis): Theoretical teratogenicity (gastroschisis, cardiac defects) – animal data; human studies inconsistent. Avoid unless benefit clearly outweighs risk.
  • Third trimester (≥30 weeks): Risk of premature closure of fetal ductus arteriosus (→ pulmonary hypertension, right heart failure), platelet dysfunction (maternal/fetal bleeding), oligohydramnios (renal prostaglandin inhibition), prolonged gestation/labor.
  • High-dose aspirin (>150 mg/day): Not indicated in pregnancy; greater risks.

Indicated Uses (Low-Dose Aspirin 75–150 mg/day)

IndicationTimingEvidence / Guideline
Preeclampsia preventionInitiate 12–16 weeks (≤28 wks); continue until delivery or 36 wksUSPSTF Grade A, ACOG, SMFM – high risk (prev PE, multifetal, chronic HTN, diabetes, renal, autoimmune) or moderate risk ×2
Antiphospholipid syndrome (APS)Preconception or early pregnancyCombined with prophylactic LMWH; specialist management
Recurrent pregnancy loss (APS-associated)PreconceptionSame as above
Fetal growth restriction prevention (selected)Early 2nd trimesterLess established; individualized

Dosing & Monitoring

  • Dose: 81 mg (US) or 75–100 mg (international) enteric-coated daily at bedtime (better compliance, possibly better effect).
  • Monitoring: BP, urine protein, uterine artery Doppler (if indicated), fetal growth scans, maternal platelet count/renal function if risk factors.
  • Discontinuation: Typically 36–37 weeks for preeclampsia prevention (balance ductus risk vs. benefit); individualized for APS.

Patient Counseling Points

  1. Do not self-start aspirin in pregnancy. Requires provider prescription & risk assessment.
  2. Inform all providers (dentist, surgeons) – bleeding risk.
  3. Stop immediately if: vaginal bleeding, signs of placental abruption, impending delivery, allergic reaction.
  4. Not a substitute for prenatal care, BP control, or indicated antihypertensives (labetalol, nifedipine, methyldopa).

Key Society Guidelines

  • ACOG Practice Bulletin 222 (2020) – Low-dose aspirin for preeclampsia prevention
  • USPSTF Recommendation (2021) – Grade A for high-risk
  • SMFM Consult Series #52 (2022)
  • ISSHP (International Society for Study of Hypertension in Pregnancy)

This is general medical information. Obstetric management must be individualized by the treating clinician.

Pregnancy & Health - Related Articles